Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus vs Sirolimus in Kidney Transplant Maintenance (DESIRE)
NCT02062892Phase 4Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Dec 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of everolimus in kidney transplantation (2 arms), sponsored by University of Colorado Denver. Primary endpoints: Creatinine Outcome Measure at 2 years, Calculated Glomerular Filtration Rate at 2 years and 3 more. Planned start Dec 2013; status: withdrawn.
02
Drugs
everolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT02062892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02062892.